MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Entera Bio Ltd. Ordinary Shares

ENTX

#3751
Entera Bio Ltd. - Ordinary Shares
1.3 5 USD
+10.66%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.35
1.35
Year Range
0.91
3.22
Daily Change
+10.66%
Monthly Change
+16.38%
6 month change
-42.55%
Year Change
-25.41%
Previous Close
1.2 2
Open
1.3 5
Low
1.3 5
High
1.3 5
Volume
1
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ENTX
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 66.45 M
  • Employee 22
  • Founded 2009
  • CEO N/A
  • Website www.enterabio.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
7.76
Price to sales ratio
2 133.59

News

Zacks Zacks
ENTX
2026.04.29
Entera Bio (ENTX) Upgraded to Buy: Here's What You Should Know
Investing Investing
ENTX
2026.03.04
Entera Bio submits streamlined Phase 3 protocol for oral osteoporosis drug
Benzinga Benzinga
ENTX
2026.02.19
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)
Investing Investing
OPK ENTX
2026.02.10
Opko Health stock rating reiterated at Buy by H.C. Wainwright
Investing Investing
ENTX
2026.02.09
Entera Bio appoints Geno Germano as board chairman
Investing Investing
ENTX
2026.02.04
OPKO and Entera expand collaboration to develop oral PTH treatment
Investing Investing
ENTX
2026.01.21
Entera Bio plans FDA submission for osteoporosis drug in Q1 2026
Investing Investing
ENTX
2025.12.24
H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint
Investing Investing
ENTX
2025.12.22
Entera Bio’s oral PTH analog shows sustained calcium response
Investing Investing
ENTX
2025.10.23
Entera Bio stock rises after positive Phase 2 bone density data
Investing Investing
ENTX
2025.10.23
Entera Bio reports positive data for oral osteoporosis treatment
Investing Investing
OPK ENTX
2025.09.25
Entera Bio stock rating reiterated at Buy by H.C. Wainwright

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd